Ideally, a value stock will have a clear reason for its recent devaluation, a strong balance sheet and long-term growth drivers. In other words, it has big problems but they can be overcome.
US healthcare equipment manufacturer Baxter International (US:BAX) meets these requirements. In 2024, Baxter was supposed to be on the brink of a strong period of growth. During the pandemic, hospitals had cut back on investment, but this was picking up again, and Baxter had just released its new Novum IQ Infusion pump, which was larger and could pump more IV fluid than previous incarnations.
Pump problems